Rochester Ophthalmological Group, PC - Brighton

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Glaucoma
• High blood pressure

Closed trials

• Completed

  Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

  NCT05397600· Phase 3· Laboratoires Thea· Source